Biomedica Biochimica Acta 1987-01-01

A comparison of the S(+) and R(-) enantiomers of 5-ethyl-5-phenylhydantoin as hypolipidemic agents in rodents.

I H Hall, J H Maguire, O T Wong, P A Day, R S Alpin

Index: Biomed. Biochim. Acta 46(7) , 623-34, (1987)

Full Text: HTML

Abstract

An investigation of the effects of the S-(+) and R-(-) enantiomers of 5-ethyl-5-phenylhydantoin as hypolipidemic agents was undertaken. The serum cholesterol and triglyceride levels were reduced approximately 40% by either oral or i.p. administration at 20 mg/kg.day of either enantiomer. Both agents blocked activities of enzymes involved in the de novo synthetic pathway of lipids. Lipids removed from the blood compartment were not deposited into tissue, but appeared to be cleared from the body at a more rapid rate. Serum lipoproteins showed a reduction in cholesterol and triglyceride content of very low density (VLDL) and low density (LDL) fractions after two-week administration at 20 mg/kg.day and HDL cholesterol content was elevated particularly with the R-(-) enantiomer. The LD50 values of the enantiomers were 500 mg/kg i.p. or greater.


Related Compounds

Related Articles:

Pharmacodynamics of cytochrome P450 2B induction by phenobarbital, 5-ethyl-5-phenylhydantoin, and 5-ethyl-5-phenyloxazolidinedione in the male rat liver or in cultured rat hepatocytes.

1993-01-01

[Chem. Res. Toxicol. 6(2) , 188-96, (1993)]

A markedly diminished pleiotropic response to phenobarbital and structurally-related xenobiotics in Zucker rats in comparison with F344/NCr or DA rats.

1992-03-03

[Biochem. Pharmacol. 43(5) , 1079-87, (1992)]

Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors.

2004-09-01

[Arch. Biochem. Biophys. 429(1) , 1-15, (2004)]

Electrochemical determination of purine and pyrimidine DNA bases based on the recognition properties of azocalix[4]arene.

2013-04-15

[J. Biochem. Toxicol. 9(5) , 269-78, (1994)]

Biopharmaceutical studies on hydantoin derivatives. V. Pharmacokinetics and pharmacodynamics of 5,5-diphenylhydantoin and 1-benzenesulfonyl-5,5-diphenylhydantoin.

1986-03-01

[J. Pharmacobiodyn. 9(3) , 303-14, (1986)]

More Articles...